搜索筛选:
搜索耗时0.0873秒,为你在为你在102,285,761篇论文里面共找到 11 篇相符的论文内容
类      型:
[会议论文] 作者:Chun-hou Liao,Shih-chieh Chueh,Ming-kuen Lai,Hong-jeng Yu, 来源:26th World Congress of Endourology & SWL(WCE 2008)(第26届国 年份:2008
[会议论文] 作者:Shun-Fa Hung,Ming-Kuen Lai,Shih-Chieh Chueh,Shiu-Dong Chung, 来源:26th World Congress of Endourology & SWL(WCE 2008)(第26届国 年份:2008
[会议论文] 作者:Chun-hou Liao,Shih-chieh Chueh,Ming-kuen Lai,Hong-jeng Yu, 来源:26th World Congress of Endourology & SWL(WCE 2008)(第26届国际腔道泌 年份:2008
[会议论文] 作者:Shun-Fa Hung,Shiu-Dong Chung,Ming-Kuen Lai,Shih-Chieh Chueh, 来源:26th World Congress of Endourology & SWL(WCE 2008)(第26届国际腔道泌 年份:2008
[期刊论文] 作者:Xue-Ke Wang,Hong-Zhen Wang,Ding-Jun Fu,Ming-Kuen Lai, 来源:亚洲男性学杂志(英文版) 年份:2012
[会议论文] 作者:Chun-hou Liao,Shih-chieh Chueh,Ming-kuen Lai,Hong-jeng Yu,Ming-hsueh Hsieh, 来源:26th World Congress of Endourology & SWL(WCE 2008)(第26届国 年份:2008
[会议论文] 作者:Shiu-dong Chung,Ming-kuen Lai,Suo-meng Wang,Shih-chieh Chueh,Kuo-how Huang,Hong-jeng Yu, 来源:26th World Congress of Endourology & SWL(WCE 2008)(第26届国 年份:2008
[会议论文] 作者:Sai-Wen Tang,Tsung-Cheng Yang,Wen-Hsin Chang,Wei-Chou Lin,Ming-Kuen Lai,Jung-Yaw Lin, 来源:第六届海峡两岸生物医学和生物工程学术会议 年份:2007
Renal cell carcinoma (RCC) is the most common malignancy in adult kidney,and accounts for 3% of malignancies worldwide with increasing incidence.Clear cell RCC (ccRCC) is the major type in RCC.Resecti...
[会议论文] 作者:Shiu-dong Chung,Ming-kuen Lai,Suo-meng Wang,Shih-chieh Chueh,Kuo-how Huang,Hong-jeng Yu, 来源:26th World Congress of Endourology & SWL(WCE 2008)(第26届国际腔道泌 年份:2008
[会议论文] 作者:Yu-Huei Liu,Chang-Yueh Lin,Saiwen Tang,Weichou Lin,Chyong-Ing Hsu,Kao-Chung Wang,Ming-Kuen Lai,Jung-Yaw, 来源:第六届海峡两岸生物医学和生物工程学术会议 年份:2007
Vascular endothelial growth factor D (VEGF-D) is a criticaal activator of tumor angiogenesis and lymphangiogenesis that recently has been implicated in the tumor metastasis process.In this study,we de...
[期刊论文] 作者:Wei-Hsien Hou,Chao-Yuan Huang,Chia-Chun Wang,Keng-Hsueh Lan,Chung-Hsin Chen,Hong-Jen Yu,Shih-Ping Liu,Ming-Kuen Lai, 来源:亚洲男性学杂志(英文版) 年份:2017
The benefit of androgen-deprivation therapy (ADT) in combination with dose-escalated radiotherapy (DERT) for localized prostate cancer has not been determined in randomized studies. In this study, the benefit of ADT was assessed in patients......
相关搜索: